Hubbry Logo
Local anesthesiaLocal anesthesiaMain
Open search
Local anesthesia
Community hub
Local anesthesia
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Local anesthesia
Local anesthesia
Local anesthesia
View on Wikipedia
from Wikipedia
Local anesthesia
MeSHD000772

Local anesthesia is any technique to induce the absence of sensation in a specific part of the body,[1] generally for the aim of inducing local analgesia, i.e. local insensitivity to pain, although other local senses may be affected as well. It allows patients to undergo surgical and dental procedures with reduced pain and distress. In many situations, such as cesarean section, it is safer and therefore superior to general anesthesia.[2]

The following terms are often used interchangeably:

  • Local anesthesia, in a strict sense, is anesthesia of a small part of the body such as a tooth or an area of skin.
  • Regional anesthesia is aimed at anesthetizing a larger part of the body such as a leg or arm.
  • Conduction anesthesia encompasses a great variety of local and regional anesthetic techniques.

Medical

[edit]
Main article: Local anesthetic

A local anesthetic is a drug that causes reversible local anesthesia and a loss of nociception. When it is used on specific nerve pathways (nerve block), effects such as analgesia (loss of pain sensation) and paralysis (loss of muscle power) can be achieved. Clinical local anesthetics belong to one of two classes: aminoamide and aminoester local anesthetics. Synthetic local anesthetics are structurally related to cocaine. They differ from cocaine mainly in that they have no abuse potential and do not act on the sympathoadrenergic system, i.e. they do not produce hypertension or local vasoconstriction, with the exception of Ropivacaine and Mepivacaine that do produce weak vasoconstriction. Unlike other forms of anesthesia, a local can be used for a minor procedure in a surgeon's office as it does not put one into a state of unconsciousness. However, the physician should have a sterile environment available before doing a procedure in their office. Local anesthetics work primarily by reversibly blocking voltage-gated sodium channels in neuronal membranes, which prevents the initiation and propagation of action potentials along sensory nerves. This blocks nociceptive signals from reaching the brain.

Local anesthetics vary in their pharmacological properties and they are used in various techniques of local anesthesia such as:

  • Topical anesthesia (surface) - Surface application on mucous membranes or skin.
  • Infiltration anesthesia: Direct injection into tissue near the site of the procedure.
  • Peripheral nerve blocks: Injection near specific nerves or plexuses (e.g., brachial, femoral).
  • Neuraxial anesthesia: Includes spinal and epidural techniques, which anesthetize broader regions through nerve root blockade.

Adverse effects depend on the local anesthetic method and site of administration discussed in depth in the local anesthetic sub-article, but overall, adverse effects can be:

  1. localized prolonged anesthesia or paresthesia due to infection, hematoma, excessive fluid pressure in a confined cavity, and severing of nerves & support tissue during injection.[3]
  2. systemic reactions such as depressed CNS syndrome, allergic reaction, vasovagal episode, and cyanosis due to local anesthetic toxicity.
  3. lack of anesthetic effect due to infectious pus such as an abscess.

History and development

[edit]

Regional anesthesia has a rich history dating back to the late 19th century, with key pioneers advancing its development. Karl Koller introduced cocaine as the first local anesthetic in 1884, revolutionizing pain management.[4]

August Bier performed the first spinal anesthesia in 1898, while James Leonard Corning explored epidural techniques.[5]

Gaston Labat, often called the "father of regional anesthesia in America," founded the American Society of Regional Anesthesia in 1923 and authored the influential textbook Regional Anesthesia: Its Technic and Clinical Application. His work standardized techniques and promoted the field's growth.[6]

Later, Manuel Martínez Curbelo pioneered continuous spinal anesthesia in the 1940s.[7]

These innovations laid the foundation for modern regional anesthesia, enabling safer, targeted pain relief.

Non-medical local anesthetic techniques

[edit]

Local pain management that uses other techniques than analgesic medication include:

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Local anesthesia

View on Grokipedia
from Grokipedia
Local anesthesia is a medical technique that involves the administration of agents to temporarily block the transmission of impulses in a specific area of the body, resulting in reversible loss of sensation without affecting the patient's consciousness or general bodily functions. These agents primarily target voltage-gated sodium channels in neuronal membranes, preventing sodium influx and thereby inhibiting and conduction in a use-dependent manner. The practice originated in the late with the discovery of cocaine's properties in 1884 by ophthalmologist Karl Koller, marking the beginning of targeted regional pain control in and . Local anesthetics are classified into two main chemical groups based on their molecular structure: (e.g., , , and ) and amino (e.g., lidocaine, bupivacaine, , and ), with the latter being more commonly used today due to greater stability and lower risk of allergic reactions. are rapidly hydrolyzed by plasma esterases, leading to shorter durations of action, while amino undergo hepatic , allowing for prolonged effects that can last from 30 minutes to over 12 hours depending on the agent, dosage, and addition of vasoconstrictors like epinephrine. represents a unique hybrid, featuring an amide linkage with an side chain that enables both hepatic and plasma , facilitating its widespread use in dental procedures. Administration methods for local anesthesia include topical application (e.g., gels or sprays for mucous membranes), infiltration (subcutaneous injection directly into tissues), peripheral nerve blocks (targeting specific ), and more advanced techniques like epidural or spinal administration for regional effects. These approaches are employed across various clinical settings, such as minor surgical procedures, dental extractions, dermatological interventions, and postoperative , providing precise analgesia while minimizing systemic side effects compared to general . Key advantages include patient awareness, reduced recovery time, and lower incidence of complications like , though risks such as local anesthetic systemic toxicity (LAST)—manifesting as seizures or cardiovascular collapse—necessitate careful dosing and monitoring, with lipid emulsion therapy as a standard .

Overview

Definition

Local anesthesia refers to the temporary loss of sensation, including , in a specific, localized area of the body without altering the patient's level of . This effect is achieved by injecting or applying medications known as local anesthetics that block nerve conduction in sensory nerves, thereby preventing the transmission of painful stimuli. Unlike broader forms of anesthesia, local anesthesia targets only the nerves supplying a small region, allowing the patient to remain awake and responsive throughout the procedure. At its physiological core, local anesthesia interrupts the propagation of action potentials along peripheral , specifically halting the relay of pain signals from the periphery to the . This blockade occurs primarily through the inhibition of voltage-gated sodium channels in neuronal membranes, which disrupts the influx of sodium ions necessary for . As a result, sensory perception in the affected area is reversibly suspended, providing targeted analgesia without systemic effects on vital functions. The scope of local anesthesia encompasses both small-scale applications, such as numbing a single skin site, and larger regional blocks that desensitize an entire limb or body quadrant while preserving overall awareness. This distinguishes it from more extensive numbing techniques that might involve or widespread physiological suppression. Common procedures utilizing local anesthesia include minor surgeries like skin biopsies, suturing of lacerations, and dental interventions such as cavity fillings or extractions, where precise, localized numbness facilitates patient comfort and procedural efficiency. It is also employed in diagnostic procedures, including breast biopsies and mole removals, ensuring minimal disruption to the patient's cognitive state.

Comparison to other anesthesia types

Local anesthesia differs fundamentally from general anesthesia in its scope and effects on patient . While local anesthesia targets specific to block sensation in a limited area without inducing , general anesthesia affects the entire body, leading to a reversible loss of , immobility, and to facilitate major surgeries. This targeted approach in local anesthesia preserves cognitive function and spontaneous breathing, contrasting with the systemic suppression required in general anesthesia, which often involves intravenous or inhaled agents and carries higher risks of respiratory depression or cardiovascular instability. Regional anesthesia, often considered a broader application under the local anesthesia umbrella, extends numbness to larger body regions such as an entire limb through peripheral blocks or central neuraxial techniques like spinal or epidural injections, whereas traditional local anesthesia is confined to small sites like or . -based methods, which primarily reduce anxiety and awareness without providing analgesia, can complement local or regional anesthesia but do not achieve the same depth of sensory blockade; for instance, monitored maintains partial consciousness for minor procedures, unlike the complete regional numbing that avoids the need for deeper systemic effects. Neuraxial techniques represent a of regional anesthesia that targets the for lower body procedures. The advantages of local anesthesia include minimized systemic exposure to drugs, resulting in fewer side effects such as or , quicker recovery times often within minutes to hours, and greater suitability for outpatient settings compared to general 's prolonged emergence and monitoring needs. However, its limitations include potential incomplete coverage for extensive surgical fields, where regional or general methods may be necessary to ensure adequate numbness. Clinicians select local anesthesia for procedures requiring patient cooperation, such as minor dermatological interventions or dental work, or when general anesthesia poses elevated risks, particularly in elderly or comorbid patients where preserving hemodynamic stability is crucial.

Pharmacology

Chemical classification

Local anesthetics are primarily classified into two chemical classes based on the nature of the linking group between the aromatic ring and the amine group in their molecular structure: and amino amides. The amino ester class includes agents such as , , , and , which feature an ester linkage that renders them susceptible to rapid by plasma pseudocholinesterases, producing para-aminobenzoic acid (PABA) as a . This metabolic pathway results in a shorter duration of action compared to amides, with half-lives ranging from less than 1 minute for to about 8 minutes for . Additionally, the formation of PABA is associated with a higher risk of allergic reactions in susceptible individuals. In contrast, the amino amide class comprises drugs like lidocaine, mepivacaine, prilocaine, , bupivacaine, and , characterized by an linkage that confers greater chemical stability. is unique among amides due to its side chain, allowing partial plasma metabolism in addition to hepatic processing. These agents are primarily metabolized in the liver through P450-mediated and , leading to slower clearance and a lower incidence of allergic reactions. Hepatic metabolism makes their pharmacokinetics more dependent on liver function and blood flow. The onset of action for local anesthetics is influenced by their pKa values, which determine the proportion of non-ionized (lipid-soluble) form available to cross membranes at physiological (7.4); lower pKa values (typically 7.6–8.0 for amides like lidocaine at 7.8) allow faster onset compared to higher pKa esters (8.5–9.0, such as at 8.9). Esters generally exhibit shorter durations due to rapid , while amides provide more prolonged effects. Potency and duration are further modulated by lipophilicity (measured by octanol/buffer partition coefficients) and protein binding; for instance, bupivacaine demonstrates high lipophilicity (partition coefficient of 560) and 95% protein binding, contributing to its long-acting profile with durations up to 210 minutes.

Mechanism of action

Local anesthetics primarily target voltage-gated sodium channels (Nav) embedded in neuronal membranes, where they bind to specific sites within the channel pore, preventing the influx of Na+ ions that is crucial for the depolarization phase of the action potential. This inhibition disrupts the rapid rise in membrane potential, thereby blocking the generation and conduction of nerve impulses without affecting the resting membrane potential. The blockade exhibits state dependence, with local anesthetics displaying higher affinity for the open and inactivated conformations of Nav channels that predominate during action potential firing, as opposed to the closed resting state. Consequently, this results in use-dependent block, where repeated or high-frequency stimulation enhances the accumulation of anesthetics in the channel, leading to more profound inhibition at clinically relevant firing rates. Several factors modulate this blockade, including pH-dependent ionization of the anesthetic molecules: the neutral (uncharged) form predominates at higher pH and facilitates passive diffusion across the lipid bilayer, while the cationic (protonated) form at lower pH binds intracellularly to the channel's activation gate to stabilize the inactivated state. Furthermore, differential sensitivity arises from nerve fiber characteristics, with smaller-diameter sensory fibers (Aδ and C types) exhibiting greater blockade than larger motor fibers (Aα and Aβ) due to shorter internodal distances, higher surface-to-volume ratios, and more accessible nodal regions for anesthetic access.

Pharmacokinetics

The pharmacokinetics of local anesthetics encompass their absorption, distribution, metabolism, and elimination, which collectively determine the onset, duration, and safety of their effects. These processes vary based on the chemical structure of the agent—primarily esters or amides—and factors such as the site of administration and co-administered additives. Absorption of local anesthetics into the systemic circulation is primarily influenced by the vascularity of the injection site, with more rapid uptake occurring in highly vascular areas such as the intercostal space or tracheal mucosa compared to less vascular sites like subcutaneous tissue or joints. The rate of absorption can be delayed by vasoconstrictors like epinephrine (typically at concentrations of 1:200,000 to 1:800,000), which reduce local blood flow and thereby lower peak plasma concentrations, extending the duration of action at the site. For example, intravenous administration of lidocaine results in an onset of action within 2-5 minutes, reflecting its rapid systemic uptake. Distribution of local anesthetics is governed by their physicochemical properties, particularly solubility, which facilitates rapid penetration into tissues, and , which limits the free fraction available for . Agents with high solubility, such as bupivacaine (octanol/buffer of 560), distribute more extensively into tissues, contributing to prolonged effects. Protein binding varies significantly; for instance, bupivacaine is approximately 95% bound to alpha-1-acid glycoprotein and , which prolongs its duration by reducing clearance of the unbound form, whereas mepivacaine exhibits only 55-75% binding. Metabolism differs markedly between ester- and amide-type local anesthetics. Esters, such as , undergo rapid in plasma by pseudocholinesterase (also known as ) into para-aminobenzoic acid (PABA) and other metabolites, often within minutes. In contrast, amides like lidocaine and bupivacaine are primarily metabolized in the liver via enzymes (e.g., and ), involving processes such as N-dealkylation and ; lidocaine, for example, produces active metabolites including monoethylglycinexylidide (MEGX), which retains about 80-90% of lidocaine's potency. , an with an ester side chain, is unique in undergoing partial plasma in addition to hepatic . Hepatic dysfunction can impair amide clearance, leading to accumulation. Elimination of local anesthetics occurs mainly through renal excretion of metabolites, with half-lives reflecting their metabolic stability. Procaine has a very short half-life of about 1 minute due to rapid ester hydrolysis, while bupivacaine's elimination half-life ranges from 3-4 hours (approximately 210 minutes), owing to its high protein binding and slower hepatic metabolism. For amides, unchanged drug constitutes less than 5-10% of urinary output, with the majority eliminated as metabolites; clearance is highly dependent on hepatic blood flow for high-extraction agents like lidocaine (half-life ~100 minutes).

Administration Techniques

Topical anesthesia

Topical anesthesia involves the non-invasive application of anesthetic agents to the surface of the skin or mucous membranes to induce localized numbness without the need for needles. This method relies on the diffusion of the anesthetic through the stratum corneum or mucosal layers to block sodium channels in sensory nerve endings, providing analgesia for superficial procedures. Common formulations include creams, gels, and sprays, which are applied directly to intact skin or accessible mucosal surfaces. Among the most widely used topical anesthetics is EMLA cream, a eutectic of 2.5% lidocaine and 2.5% prilocaine that forms an oil-in-water for enhanced penetration. This cream is applied under an occlusive dressing and is effective for dermatological procedures due to its ability to numb the and upper . Other formulations include gels such as ELA-MAX (4% liposomal lidocaine) and sprays like 10% lidocaine, which offer quicker application for minor interventions. For improved delivery, employs a low-level to drive charged anesthetic molecules, such as lidocaine hydrochloride, across the skin barrier, reducing onset time compared to passive alone. Topical anesthetics are particularly suited for skin procedures like minor laceration repairs, laser treatments, and , where EMLA cream has been shown to significantly reduce pain during needle insertion in both adults and children. On mucosal surfaces, such as the oral cavity or throat, sprays and gels provide rapid numbing for procedures including endotracheal or dental examinations; for instance, lidocaine sprays alleviate discomfort during . These agents also find use in for corneal anesthesia and in for urethral procedures, though efficacy varies by site due to differences in tissue permeability. Benzocaine, available over-the-counter in concentrations up to 20% in gels and sprays, is commonly used for temporary relief of oral , such as sore throats or in infants, due to its rapid onset on mucous membranes. Tetracaine, often in 0.5% to 4% formulations or combined with lidocaine in creams like Synera (lidocaine 70 mg/ 70 mg per patch), provides stronger and deeper for more invasive superficial procedures, such as dermal suturing, owing to its higher potency and longer duration compared to amide-based agents alone. The primary advantages of topical anesthesia include its needle-free administration, which minimizes patient anxiety and infection risk, and limited systemic absorption when applied to intact , resulting in peak plasma levels well below toxic thresholds for standard doses. However, limitations include a relatively slow onset of 30 to 60 minutes for creams like EMLA under occlusion, restricting its use in time-sensitive settings, and shallow of 2 to 5 mm, making it unsuitable for deeper tissues. On broken skin or large areas, there is a potential for increased absorption leading to , particularly with , necessitating careful dosing and monitoring.

Infiltration and field block

Infiltration anesthesia is a fundamental technique in local anesthesia that involves the direct subcutaneous or of a local agent into the tissue surrounding the procedure site, allowing the solution to diffuse to nearby free endings and provide localized sensory . This method is particularly suited for superficial procedures, such as the excision of skin lesions, where the bathes the terminal fibers without requiring precise targeting. Commonly, a 1-2% lidocaine solution is used for these applications, as it offers rapid onset and adequate duration for minor dermatologic interventions. The procedure begins with skin preparation using an , followed by insertion of a 25- to 30-gauge needle attached to a containing the ; aspiration is performed to confirm avoidance of intravascular injection before slow infusion to minimize patient discomfort and tissue distortion. Field block anesthesia extends the principles of infiltration by administering multiple injections in a circumferential around the operative area to create a "wall" of , thereby blocking multiple small peripheral nerves collectively and numbing a broader field without distorting the surgical site. This approach is effective for procedures involving larger superficial areas, such as repair, where the anesthetic is injected to encircle the incision site and interrupt sensory input from the ilioinguinal, iliohypogastric, and genitofemoral nerves. In such cases, the technique involves landmark-based or guided injections into the subcutaneous and fascial planes, ensuring comprehensive coverage while preserving muscle function. Addition of a vasoconstrictor like epinephrine to the local anesthetic solution can prolong the block's duration and limit systemic absorption, though detailed pharmacokinetics are discussed elsewhere. Dosage considerations are critical to prevent local anesthetic systemic toxicity, with the maximum recommended dose for lidocaine being 4.5 mg/kg without epinephrine (up to 300 mg total) and 7 mg/kg with epinephrine (up to 500 mg total) for adults, calculated based on and adjusted for the procedure's scope. Volume selection depends on the target area size and tissue tolerance, typically ranging from 5-20 mL per site to balance efficacy and minimize swelling, with dilution if necessary for larger fields. Essential tools include 3- to 10-mL syringes and short-beveled needles (25-27 gauge) for precise delivery; guidance may be employed for enhanced accuracy, particularly in field blocks, by visualizing muscle layers and fascial planes to optimize injection placement and reduce complications.

Peripheral nerve blocks

Peripheral nerve blocks involve the targeted injection of local anesthetics near specific peripheral nerves to produce regional anesthesia and analgesia for a defined body area, such as a limb, by interrupting nerve conduction without affecting the . These blocks are particularly useful for procedures requiring numbness in larger regions, offering advantages over systemic analgesia by reducing use and enabling faster recovery. Techniques for peripheral nerve blocks include single-shot injections, where a one-time dose of local anesthetic is administered to achieve temporary blockade lasting several hours, and continuous catheter methods, which involve placing a catheter near the for intermittent or infusion delivery to provide prolonged analgesia, often extending into the postoperative period. A common example is the , used for upper extremity surgery, which can target the at various sites such as the interscalene or supraclavicular levels to anesthetize the , , or hand. Guidance for accurate needle placement is essential to minimize risks and improve efficacy, with ultrasound emerging as the preferred method due to its ability to visualize nerves, surrounding structures, and the spread of anesthetic in real time, reducing the volume of drug needed and increasing success rates compared to traditional approaches. Nerve stimulators provide an alternative or adjunct by delivering low electrical currents to elicit muscle twitches, confirming proximity to the target nerve, while anatomical landmarks, such as the interscalene groove formed by the sternocleidomastoid muscle and clavicle, guide blind or paresthesia-based techniques in resource-limited settings. Local anesthetics for peripheral nerve blocks are selected based on duration and potency; longer-acting agents like (0.2-0.5% concentrations) are favored for postoperative due to their extended blockade (up to 12-24 hours) and lower profile compared to bupivacaine. Specific complications of peripheral nerve blocks include , with transient neurological dysfunction occurring in approximately 1% of cases (9 per 1,000) and persistent injury in about 0.03% (0.3 per 10,000), often linked to direct needle trauma, intraneural injection, or pressure from , though guidance may reduce this risk. Infection risk, while low, arises from breaches in aseptic technique during catheter placement, potentially leading to or , and is mitigated by strict sterile protocols.

Neuraxial techniques

Neuraxial techniques involve the administration of local anesthetics into the central neuraxial space to achieve and analgesia for procedures affecting the lower body or . These methods target the subarachnoid or epidural spaces surrounding the , providing a dense block of sensory, motor, and sympathetic nerves. Spinal delivers a single injection directly into the (CSF), while epidural uses a for repeated or continuous dosing, allowing for prolonged effects. Both techniques rely on the of local anesthetics to nerve roots, but they differ in onset, duration, and control over the block level. Spinal anesthesia is performed by injecting a local into the subarachnoid space via , typically at the L3-L4 or L4-L5 interspace using a fine-gauge needle (e.g., 25-27 gauge pencil-point). This single intrathecal injection produces a rapid onset of block within 5-8 minutes, with a duration of 90-150 minutes depending on the agent and dose. Bupivacaine, often in a 0.5% concentration at 10-15 mg, is commonly used for procedures such as cesarean sections, providing reliable sensory and motor blockade from the sacral to thoracic levels. The technique requires patient positioning (sitting or lateral decubitus) to control spread, and confirmation of CSF flow ensures accurate placement. Epidural anesthesia involves inserting a into the , usually via a Tuohy needle at (L2-L4) or thoracic levels (T10-T12 for upper abdominal coverage), allowing for intermittent boluses or continuous . This method has a slower onset (10-20 minutes) but enables of dosing to maintain analgesia over hours or days, making it suitable for labor or postoperative . Local anesthetics like bupivacaine (0.0625-0.125%) or are administered at 5-10 mL boluses, often combined with opioids for enhanced effect, with the advanced 3-5 cm into the space after loss-of-resistance confirmation. Thoracic epidurals require a paramedian approach to avoid above L1. The spread of the anesthetic solution in spinal (and sometimes epidural) techniques is influenced by baricity, defined as the of the solution relative to CSF (approximately 1.0069 g/mL at 37°C). Hyperbaric solutions, such as bupivacaine mixed with 8% dextrose, are denser than CSF and settle dependently under , allowing predictable control of block height by patient positioning (e.g., Trendelenburg for higher spread). Isobaric solutions, like plain 0.5% bupivacaine, have equivalent and spread more uniformly regardless of posture, resulting in less predictable but often mid-thoracic levels. Hyperbaric formulations are preferred for targeted lower-body due to their reliability in achieving sacral-to-T10 . A key risk of neuraxial techniques is , arising from sympathectomy-induced and reduced venous return, which can occur in up to 20-30% of cases and is more abrupt with spinal due to its rapid onset. This is managed with intravenous fluids, leg elevation, and vasopressors such as (50-100 mcg boluses). Post-dural puncture headache (PDPH), specific to dural breach in spinal or accidental epidural punctures, results from CSF leakage causing intracranial , with an incidence of 1-2% using modern needles; symptoms include positional , , and , treated conservatively or with . Both risks underscore the need for vigilant hemodynamic monitoring and patient selection.

Clinical Applications

Dentistry and oral procedures

Local anesthesia is widely employed in dentistry to facilitate pain-free procedures by temporarily blocking conduction in the oral cavity, allowing patients to remain conscious throughout treatment. In dental practice, it is essential for managing discomfort during restorative and surgical interventions, with techniques tailored to the unique of the and . The most commonly used agent is 2% lidocaine with epinephrine, which provides reliable pulpal anesthesia lasting 60-90 minutes for infiltration and up to 3 hours for blocks, making it suitable for a range of procedures. , often in a 4% solution with epinephrine, is preferred for mandibular procedures due to its faster —typically 1.5-3.6 minutes for blocks—attributed to its unique ring structure enhancing diffusion through bone. This rapid onset is particularly beneficial in the denser mandibular bone, where articaine achieves pulpal anesthesia more effectively than lidocaine in cases of irreversible . Techniques in vary by jaw. For maxillary procedures, local infiltration anesthesia is standard, involving direct injection into soft tissues near the apex, which is effective due to the maxilla's porous cortical allowing easy anesthetic diffusion. In contrast, mandibular anesthesia often requires an block (IANB), where the anesthetic is deposited near the to numb the lower teeth, lips, and ; this block is commonly supplemented with buccal or lingual infiltrations for comprehensive coverage. These methods, akin to peripheral nerve blocks, ensure targeted numbness while minimizing systemic spread. Applications include tooth extractions, restorative fillings, and endodontic treatments like root canals, where profound anesthesia prevents intraoperative and postoperative discomfort. In , lower doses are mandated to avoid toxicity; for instance, the maximum safe dose of lidocaine is 4.4 mg/kg, with adjustments based on weight and concurrent sedatives to enhance safety during procedures such as pulpotomies or extractions. The primary advantages of local anesthesia in oral procedures are enabling awake patient participation, which reduces anxiety and allows immediate feedback, and offering minimal recovery time—typically 1-4 hours for sensation to return—facilitating same-day discharge without lingering effects.

Minor surgery and

Local anesthesia plays a crucial role in minor surgical procedures and dermatological interventions, enabling outpatient management of and conditions with minimal invasiveness. Common applications include biopsies for diagnostic of suspicious lesions, excisions of benign or malignant growths such as cysts or basal cell carcinomas, and laser treatments for vascular anomalies, pigmentation disorders, or . These procedures benefit from local anesthesia's ability to provide targeted numbness, allowing precise intervention while preserving patient mobility and reducing recovery time compared to general . Techniques for administering local anesthesia in vary by lesion depth and procedure type. For superficial procedures like minor biopsies or resurfacing, topical anesthetics—such as eutectic mixtures of lidocaine and prilocaine—are applied to intact to achieve analgesia without injection-related distortion. In contrast, infiltration anesthesia, involving direct subcutaneous injection of agents like lidocaine or bupivacaine, is preferred for deeper lesions requiring excision, ensuring complete blockade of sensory nerves in the operative field. These methods prioritize rapid onset and duration matched to procedure length, typically 30-60 minutes. A specialized application is tumescent anesthesia, particularly in dermatologic liposuction for body contouring. This involves infusing large volumes of dilute lidocaine (typically 0.05-0.1% solution with epinephrine) into subcutaneous fat, causing tissue swelling and firming for easier fat removal while providing prolonged anesthesia and hemostasis. Safe maximal doses reach 35-55 mg/kg, with peak plasma levels delayed due to slow absorption, minimizing systemic toxicity risks in outpatient settings. This technique has revolutionized ambulatory liposuction by enabling large-volume fat extraction without general anesthesia. Key considerations in these applications include optimizing patient comfort and achieving favorable cosmetic outcomes. Buffering anesthetic solutions with reduces injection pain, enhancing tolerability during infiltration, while careful site selection and minimal tissue trauma support scar minimization and aesthetic results. For patients with suspected allergies, ester-type anesthetics (e.g., ) require prior prick or intradermal testing due to higher risk from para-aminobenzoic acid metabolites, often prompting a switch to amides like lidocaine. Modern innovations, such as self-warming lidocaine-tetracaine patches, offer noninvasive pre-procedure numbing for enhanced comfort in dermatologic settings. Applied for 20-30 minutes, these patches induce effective local anesthesia for minor procedures like or superficial laser treatments, with clinical trials demonstrating significant pain reduction and low adverse event rates. This approach is particularly valuable for pediatric or anxious patients, streamlining office-based care.

Obstetrics and pain management

In obstetrics, local anesthesia plays a central role in managing labor pain, with epidural analgesia being the most widely used technique for providing effective relief during the first and second stages of labor. involves injecting local anesthetics, often combined with opioids, into the to block pain signals from the and birth canal, allowing women to remain awake and participate in the birthing process. As of 2024, this method is utilized by more than 70% of laboring individuals in the United States and approximately 22% in the , offering superior pain reduction compared to non-epidural options while increasing maternal satisfaction. A 2024 study also found that epidural use is associated with a 35% reduction in severe maternal morbidity. For the second stage of labor, particularly during , blocks provide targeted analgesia to the and by injecting local anesthetic near the via a transvaginal approach, facilitating procedures like or forceps-assisted birth without affecting . For cesarean sections, spinal anesthesia is the standard regional technique due to its rapid and reliability in achieving a dense sensory block from the T4 dermatome level downward, enabling the procedure under controlled conditions while minimizing risks associated with general . This single-injection method uses hyperbaric local s like bupivacaine, typically administered at doses around 10-12 mg, to provide surgical lasting 1-2 hours. In cases requiring prolonged postoperative analgesia or where conversion to labor might occur, combined spinal-epidural (CSE) anesthesia is preferred, as it combines the quick onset of intrathecal injection with the flexibility of an epidural for bolus extensions or infusions. CSE reduces the total anesthetic dose needed and enhances hemodynamic stability compared to standalone spinal techniques. Beyond , local anesthesia via peripheral blocks is integral to acute and postoperative , targeting specific to alleviate discomfort from trauma or while avoiding widespread effects. These blocks, such as single-injection or continuous infusions of local anesthetics like , effectively control in scenarios including postoperative recovery and neuropathic conditions, significantly reducing the need for systemic opioids and associated side effects like respiratory depression. For instance, intercostal blocks are particularly useful for managing severe from rib fractures, where ultrasound-guided injection of 3-5 mL of anesthetic per level interrupts transmission along the intercostal , improving respiratory function and shortening hospital stays compared to opioid-only regimens. In obstetric contexts, continuous fetal monitoring is essential during these neuraxial techniques to detect potential changes, such as from maternal , ensuring timely interventions.

Ophthalmology and other specialties

In ophthalmology, local anesthesia is essential for both diagnostic examinations and surgical interventions, minimizing patient discomfort while preserving globe integrity. Topical anesthetics, such as 0.5% proparacaine hydrochloride drops, are commonly applied for routine eye examinations and minor procedures like tonometry or foreign body removal, providing rapid corneal anesthesia without the need for needles. For intraocular surgeries, such as cataract extraction, retrobulbar blocks are frequently employed, involving the injection of local anesthetics like lidocaine or bupivacaine into the retrobulbar space to achieve akinesia and analgesia of the extraocular muscles and optic nerve. This technique, typically using 3-5 mL of anesthetic solution, ensures surgical stillness but requires careful monitoring to avoid complications like globe perforation. Post-administration of topical agents, corneal protection is critical due to the potential for epithelial toxicity and delayed healing; measures such as lubricating ointments or eyelid taping are applied to safeguard the ocular surface during recovery. Beyond , local anesthesia finds specialized applications in otolaryngology (ENT), where nasal nerve blocks facilitate endoscopic sinus surgery and . Techniques like the lateral nasal wall block target the anterior ethmoidal and sphenopalatine nerves using lidocaine-soaked pledgets or direct injections, reducing bleeding and providing targeted analgesia without general anesthesia. In , dorsal penile nerve blocks are a standard for procedures involving the , such as or reduction, achieved by injecting 1-2 mL of 1% lidocaine bilaterally at the penile base to block sensory innervation from the branches. This method offers effective regional anesthesia with minimal systemic absorption when proper dosing is maintained. In , caudal is widely used for lower abdominal and perineal surgeries, including repairs, particularly in infants and young children to avoid general risks. Performed via the sacral hiatus with 0.5-1 mL/kg of or bupivacaine, it provides reliable sensory blockade up to the T10 dermatome, allowing for procedures with reduced postoperative pain. Dose adjustments are paramount in small patients to prevent , with maximum volumes calculated based on age and weight—typically 0.5 mL/kg for neonates—to stay below safe plasma thresholds. Emerging advancements include ultrasound-guided local anesthetic injections in orthopedics, enhancing precision for joint procedures like intra-articular or injections. Real-time imaging allows for accurate needle placement within synovial spaces, improving efficacy for conditions such as or , with studies showing reduced procedural pain and fewer complications compared to landmark-based methods.

Adverse Effects and Safety

Local reactions

Local reactions to local anesthetics encompass tissue-specific adverse responses occurring at the site of injection or topical application, including , bruising, , and allergic manifestations. upon injection is a frequent immediate response, resulting from the mechanical trauma of needle insertion and the acidic of the anesthetic solution, which irritates endings. Bruising, or hematoma formation, arises from vascular laceration during injection, leading to localized and discoloration that typically resolves within days to weeks. , characterized by swelling due to fluid accumulation and inflammatory response, commonly affects facial or perioral tissues following dental or minor procedures. Allergic reactions at the local site, such as or , are less common and often linked to ester-type anesthetics like , which can trigger IgE-mediated due to their metabolism into para-aminobenzoic acid (PABA). These reactions manifest as localized , itching, or wheal-and-flare responses shortly after administration. Amide-type agents like lidocaine are rarely implicated in true allergies, with most reported cases attributable to preservatives or additives. Rarer local complications include tissue necrosis, primarily associated with vasoconstrictors such as epinephrine in the anesthetic solution, which can cause ischemia in areas with compromised vascular supply, such as the or . This may occur due to excessive or high-pressure injection leading to vascular compression and subsequent sloughing of tissue. Infections at the injection site, though uncommon when sterile technique is employed, can result from bacterial contamination, presenting as abscesses or . The incidence of most local reactions, including bruising, edema, and minor pain, is generally low at less than 1% per procedure, though allergic responses occur in approximately 0.1-1% of cases, with higher rates observed in patients with repeated exposures or predisposing atopic conditions. True hypersensitivity reactions remain rare, affecting fewer than 1% of administrations. Management of common local reactions focuses on symptomatic relief: application of ice packs reduces pain and by vasoconstriction and numbing, while limb elevation minimizes swelling in extremity injections. For bruising, gentle compression and avoidance of anticoagulants aid resolution. Allergic urticaria is treated with oral antihistamines like diphenhydramine to block release and alleviate itching. In cases of or , prompt , antibiotics, or surgical intervention may be required, emphasizing the importance of vigilant post-procedure monitoring.

Systemic toxicity

Systemic toxicity from local anesthetics, also known as local anesthetic systemic toxicity (LAST), occurs when excessive amounts of the drug enter the bloodstream, either due to overdose or unintended intravascular injection, leading to adverse effects on the (CNS) and cardiovascular system. This condition is rare but potentially life-threatening, with symptoms typically manifesting within minutes of administration. The progression of LAST generally follows two main stages affecting the CNS. Initial excitation arises from blockade of inhibitory pathways in the , resulting in symptoms such as , perioral numbness, agitation, visual or auditory disturbances, and muscle twitching, which may escalate to generalized seizures. This is followed by a depressive phase as higher blood concentrations suppress both inhibitory and facilitatory pathways, causing drowsiness, loss of consciousness, respiratory depression, and . Cardiovascular effects often accompany or follow CNS symptoms, manifesting as hypotension, bradycardia, conduction abnormalities, and arrhythmias, potentially culminating in cardiovascular collapse or cardiac arrest. Bupivacaine is particularly associated with severe cardiotoxicity due to its high affinity for cardiac sodium channels, which prolongs the QRS complex and predisposes to re-entrant ventricular arrhythmias that are resistant to standard resuscitation efforts. Additionally, certain local anesthetics can cause , particularly prilocaine, , and to a lesser extent lidocaine or , especially with high-dose topical applications. This condition involves oxidation of to , reducing oxygen-carrying capacity and leading to symptoms such as , , , , and , even at normal levels. It is dose-dependent and more common in infants or patients with . Management includes supplemental oxygen, discontinuation of the agent, and administration of intravenous (1-2 mg/kg over 5 minutes) to reduce levels. To mitigate the risk of systemic toxicity, maximum recommended doses are established based on the agent's properties and patient factors. For plain lidocaine (without epinephrine), the maximum dose is 4.5 mg/kg to avoid exceeding safe plasma levels. Risk is heightened in patients with impaired hepatic , such as those with , as this delays clearance and elevates systemic exposure. Management of LAST prioritizes supportive care and specific antidotal therapy. is essential, including oxygenation and if respiratory depression occurs, alongside control with benzodiazepines. Intravenous emulsion therapy, such as 20% Intralipid, serves as the cornerstone treatment by sequestering the lipophilic anesthetic from target tissues; a typical regimen involves an initial bolus of 1.5 mL/kg over 1 minute, followed by an infusion of 0.25 mL/kg/min until stability is achieved.

Contraindications and management

Contraindications to local anesthesia are categorized as absolute or relative, guiding patient selection to minimize risks of adverse reactions or complications. Absolute contraindications include known or to the local anesthetic agent or its chemical class, such as (e.g., lidocaine, bupivacaine) or esters (e.g., ), which can precipitate or severe allergic responses. In patients with severe hepatic impairment, local anesthetics are generally avoided due to their primary via the liver, potentially leading to accumulation and heightened risk. Relative contraindications encompass conditions where local anesthesia may be used with caution, dose adjustments, or alternative agents. These include active at the injection site, which risks disseminating into deeper tissues or bloodstream, and coagulopathies or therapy, increasing formation potential, particularly for blocks. Severe warrants careful selection, often limiting vasoconstrictor use (e.g., epinephrine) to avoid hemodynamic instability. represents a relative requiring risk-benefit assessment; lidocaine is classified as FDA B, indicating no evidence of risk in and limited supporting , while bupivacaine is Category C, with showing potential fetal risk but insufficient for definitive exclusion. Safe management of local anesthesia emphasizes prevention of systemic toxicity through precise dosing and monitoring. Maximum doses are calculated using formulas based on patient weight and toxicity thresholds derived from clinical studies on plasma levels causing or cardiovascular effects; for example, the maximum dose of lidocaine without vasoconstrictor is 4.5 mg/kg (not exceeding 300 mg total), computed as: maximum dose (mg) = maximum mg/kg × patient weight (kg), then converted to volume by dividing by concentration (e.g., 10 mg/mL for 1% solution). Similar limits apply to bupivacaine at 2.5 mg/kg with vasoconstrictor (maximum 225 mg), reflecting its cardiotoxic profile at lower plasma concentrations compared to lidocaine. When local anesthesia is combined with , (BIS) monitoring assesses depth via processed electroencephalogram, targeting a BIS value of 40-60 to avoid or oversedation, as validated in procedural settings like spinal . The American Society of Regional Anesthesia and Pain Medicine (ASRA) provides key guidelines for safe regional anesthesia administration, recommending the lowest effective dose, guidance to enhance precision and reduce inadvertent intravascular injection, incremental injection techniques with frequent aspiration, and individualized for high-risk patients to prevent local anesthetic systemic toxicity.

History and Developments

Early discoveries

The discovery of local anesthesia began in the late with the identification of cocaine's anesthetic properties, marking a pivotal shift from general anesthesia's risks for minor procedures. In 1884, Austrian ophthalmologist Karl Koller demonstrated cocaine's efficacy as a during , applying a 2-4% solution to the to achieve profound analgesia without affecting consciousness. This breakthrough, presented at a meeting of the Ophthalmological Society of , enabled painless intraocular operations and is recognized as the first clinical use of a local anesthetic. Building on Koller's work, cocaine's application expanded to peripheral nerve blocks in 1885. American surgeon William Halsted, collaborating with Richard Hall, injected cocaine solutions around sensory nerves in the arm and oral cavity, pioneering regional anesthesia techniques such as blocks for limb surgeries and blocks for dental procedures. Concurrently, , an early advocate of cocaine's therapeutic potential, published enthusiastic endorsements of its use for various ailments, including as a local anesthetic, though his promotion later drew scrutiny due to emerging concerns. These innovations facilitated safer, targeted pain control in . A significant advancement occurred in 1898 when German surgeon introduced spinal anesthesia by injecting directly into the subarachnoid space, achieving lower-body analgesia for lower limb and abdominal surgeries. Bier's self-experimentation with his assistant Hildebrandt confirmed the technique's feasibility, using a 0.5% solution via , which revolutionized operative safety for procedures below the diaphragm. This neuraxial method, detailed in Bier's subsequent report, laid the foundation for modern epidural and spinal blocks. Despite these triumphs, early use of revealed substantial challenges, particularly its systemic toxicity, which manifested as convulsions, cardiovascular collapse, and fatalities even at therapeutic doses. Reports of adverse reactions, including deaths during ophthalmic and surgical applications, prompted urgent investigations into safer alternatives by the early , highlighting the need for less toxic agents while preserving local anesthetic efficacy.

Synthetic agents and modern advancements

The development of synthetic local anesthetics marked a significant shift from reliance on , offering safer alternatives with reduced toxicity profiles. In 1904, German chemist Alfred Einhorn synthesized , the first synthetic ester-type local anesthetic, which was marketed as Novocain and rapidly became the standard for injectable anesthesia due to its lower risk of and systemic effects compared to . The mid-20th century saw further innovations in amide-type synthetics, which offered greater stability and potency. Lidocaine, synthesized in 1943 by Swedish chemist Nils Löfgren and introduced clinically in 1948 under the name Xylocaine, revolutionized local anesthesia with its rapid onset, versatility for infiltration, nerve blocks, and topical use, and lower allergenicity than esters like procaine. In the 1960s, bupivacaine emerged as a long-acting amide anesthetic, synthesized in 1957 and marketed in 1965, providing prolonged analgesia ideal for surgical procedures but initially raising concerns over its cardiotoxicity at high doses. Modern synthetic agents have prioritized enhanced safety margins, particularly in reducing cardiac risks. , an S-enantiomer derivative of mepivacaine introduced in 1996, demonstrated lower cardiotoxicity than bupivacaine in preclinical and clinical studies, with a higher threshold for arrhythmogenic effects while maintaining similar duration, making it preferable for high-volume blocks. In the 2010s, liposomal bupivacaine (marketed as Exparel and FDA-approved in ) advanced prolonged-release s by encapsulating bupivacaine in multivesicular liposomes, enabling sustained release over 72 hours and reducing peak plasma concentrations to minimize systemic toxicity in postoperative . A similar extended-release bupivacaine , Posimir, was FDA-approved in 2021 for infiltration into surgical sites. Technological and pharmacological advancements have further refined local anesthesia delivery and safety. Ultrasound guidance, popularized in the 2000s, improved block success rates and reduced complications like vascular puncture by allowing real-time visualization of needle placement and anatomy, with studies showing shorter onset times and lower anesthetic volumes needed. Targeted delivery systems, including nanoparticle-based and hydrogel-encapsulated formulations developed in the and , enable site-specific release of synthetics like bupivacaine, extending duration while limiting systemic exposure; for instance, thermoresponsive hydrogels achieve controlled release triggered by body temperature, enhancing efficacy in peripheral blocks. Ongoing into reduced focuses on molecular modifications, such as chirally pure enantiomers and -bound carriers, which have increased the convulsive and cardiovascular thresholds of agents like by approximately 50% compared to racemic mixtures like bupivacaine in animal models, alongside therapies for reversing systemic .

Non-Medical Uses

Alternative anesthetic methods

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive technique that applies low-voltage electrical currents through electrodes on the skin to modulate pain signals, mimicking aspects of local anesthesia by interfering with nerve transmission. This method operates on the gate control theory of pain, which posits that stimulation of non-nociceptive fibers can "gate" or inhibit the transmission of pain signals at the spinal cord level. Proposed by Melzack and Wall in 1965, the theory provides the foundational mechanism for TENS, where electrical impulses preferentially activate large-diameter afferent fibers to reduce the perception of localized pain without pharmacological agents. Cryoanalgesia involves the application of extreme cold to targeted s, temporarily disrupting their ability to conduct pain signals and producing numbness similar to local anesthetic effects. Developed in the , this technique uses probes or cryodevices to freeze tissues to temperatures around -50°C to -70°C, slowing ionic exchanges across membranes and halting impulse propagation for periods ranging from days to months, depending on the application. In non-medical contexts, simpler cold applications like packs can achieve short-term superficial numbing by reducing excitability through and decreased metabolic activity. Acupuncture employs the insertion and manual or electrical stimulation of fine needles at specific body points to induce localized analgesia, drawing from principles to balance energy flow and modulate pathways. indicates that needle stimulation triggers local release of and other neuromodulators, which inhibit signaling in affected areas, providing relief for conditions like musculoskeletal . This approach can produce targeted hypoalgesia without drugs, though effects vary by individual response to de sensation—a tingling or numbing feeling at the site. These alternative methods generally offer less reliable and shorter-duration analgesia compared to pharmacological local anesthetics, with evidence showing inconsistent efficacy across users and pain types, often necessitating adjunctive use rather than standalone application. For instance, TENS provides variable pain relief in chronic conditions due to factors like electrode placement and intensity, while cryoanalgesia's effects are transient and not suitable for precise surgical numbing. Acupuncture's benefits, though supported for certain pains, lack uniformity and may not achieve the rapid, profound blockade of drug-based methods.

Over-the-counter products

Over-the-counter (OTC) local anesthetics primarily include topical formulations of lidocaine and , designed for safe self-administration in minor pain relief. Lidocaine is available in creams, gels, ointments, and patches at concentrations up to 5%, commonly used for conditions such as , minor skin irritations, and post-procedure discomfort. , an ester-type anesthetic, is found in sprays, lozenges, and gels, often at 5-20% concentrations, and is marketed for oral pain relief including in older children and sore throats. Regulatory oversight by the U.S. (FDA) restricts OTC lidocaine to a maximum of 5% to minimize absorption and systemic risks, with warnings against applying it over large areas or using concentrations above 4% for certain sensitive uses. For , the FDA has issued specific cautions due to the risk of , a potentially life-threatening blood disorder, particularly in children under 2 years old, leading to recommendations against its use in products for infants. These products are intended for temporary relief of from minor burns, sunburns, bites, scrapes, and, in some cases, prior to procedures like tattoos, though high-concentration applications for tattoos have prompted FDA warnings due to concerns. Misuse, such as excessive application or ingestion, can result in local anesthetic systemic (LAST), manifesting as seizures, cardiac arrhythmias, or respiratory distress, emphasizing the need for adherence to labeled instructions. The availability of these low-dose OTC local anesthetics expanded following the FDA's OTC Drug Review initiated in 1972, which evaluated and reclassified certain topical agents as safe for consumer use without prescription when used as directed.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK430894/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3403589/
  3. https://my.clevelandclinic.org/health/procedures/local-anesthesia
  4. https://madeforthismoment.asahq.org/anesthesia-101/types-of-anesthesia/local-anesthesia/
  5. https://emedicine.medscape.com/article/873879-overview
  6. https://www.bjaed.org/article/S2058-5349%2819%2930152-0/fulltext
  7. https://madeforthismoment.asahq.org/anesthesia-101/types-of-anesthesia/
  8. https://my.clevelandclinic.org/health/treatments/15286-anesthesia
  9. https://www.nigms.nih.gov/education/fact-sheets/Pages/anesthesia
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC4461791/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC7808030/
  12. https://pubmed.ncbi.nlm.nih.gov/16101448/
  13. https://academic.oup.com/bja/article/89/1/52/256293
  14. https://www.sciencedirect.com/science/article/pii/S0889853705701619
  15. https://www.ncbi.nlm.nih.gov/books/NBK539881/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC4676230/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC5564188/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC9993209/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC10121092/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC4052077/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC6464542/
  22. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/safety-information-benzocaine-containing-products
  23. https://www.ncbi.nlm.nih.gov/books/NBK582601/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC4107876/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC5999301/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC9871143/
  27. https://www.ncbi.nlm.nih.gov/books/NBK553090/
  28. https://www.ncbi.nlm.nih.gov/books/NBK459210/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3145343/
  30. https://pubmed.ncbi.nlm.nih.gov/37940348/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC9345828/
  32. https://www.nysora.com/techniques/spinal-anesthesia-2/
  33. https://www.ncbi.nlm.nih.gov/books/NBK542219/
  34. https://www.ncbi.nlm.nih.gov/books/NBK580480/
  35. https://www.ncbi.nlm.nih.gov/books/NBK610935/
  36. https://www.nature.com/articles/s41405-021-00082-5
  37. https://onlinelibrary.wiley.com/doi/10.1111/iej.13215
  38. https://www.ncbi.nlm.nih.gov/books/NBK564368/
  39. https://www.msdmanuals.com/professional/dental-disorders/how-to-do-dental-procedures/how-to-do-an-inferior-alveolar-nerve-block
  40. https://www.aapd.org/globalassets/media/policies_guidelines/bp_localanesthesia.pdf
  41. https://www.jaad.org/article/S0190-9622%2816%2900074-8/fulltext
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC2840913/
  43. https://pubmed.ncbi.nlm.nih.gov/29339237/
  44. https://www.jaad.org/article/S0190-9622%2888%2970213-3/fulltext
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC2840906/
  46. https://journals.lww.com/anesthesia-analgesia/fulltext/2016/05000/estimated_maximal_safe_dosages_of_tumescent.21.aspx
  47. https://onlinelibrary.wiley.com/doi/abs/10.1002/der2.80
  48. https://jcadonline.com/optimizing-local-anesthesia-use/
  49. https://pubmed.ncbi.nlm.nih.gov/8826570/
  50. https://www.jacionline.org/article/S0091-6749%2818%2930583-9/fulltext
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC3366310/
  52. https://pubmed.ncbi.nlm.nih.gov/15841628/
  53. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021623s015s017lbl.pdf
  54. https://evidencebasedbirth.com/epidural-during-labor-pain-management/
  55. https://www.bmj.com/content/385/bmj-2023-077190
  56. https://pubmed.ncbi.nlm.nih.gov/35277971/
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC6494646/
  58. https://www.ncbi.nlm.nih.gov/books/NBK551518/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC8966974/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC8728877/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC10971816/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC6786885/
  63. https://pubmed.ncbi.nlm.nih.gov/10935011/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC11456737/
  65. https://pubmed.ncbi.nlm.nih.gov/27871587/
  66. https://www.ncbi.nlm.nih.gov/books/NBK482273/
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC4157932/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC10820310/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC8923310/
  70. https://eyewiki.org/Retrobulbar_Anesthesia
  71. https://www.nysora.com/techniques/head-and-neck-blocks/local-regional-anesthesia-ophthalmic-surgery/
  72. https://eyewiki.org/Topical_Anesthetic_Abuse_Keratopathy
  73. https://pubmed.ncbi.nlm.nih.gov/36514428/
  74. https://www.ncbi.nlm.nih.gov/books/NBK535389/
  75. https://emedicine.medscape.com/article/81077-overview
  76. https://www.ncbi.nlm.nih.gov/books/NBK551693/
  77. https://www.nysora.com/techniques/neuraxial-and-perineuraxial-techniques/caudal-anesthesia/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC6611943/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC8399637/
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC6301842/
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC8637917/
  82. https://pubmed.ncbi.nlm.nih.gov/29952645/
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC11340848/
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC8407628/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC5586559/
  86. https://pmc.ncbi.nlm.nih.gov/articles/PMC9171334/
  87. https://www.ncbi.nlm.nih.gov/books/NBK499964/
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC5667269/
  89. https://journals.lww.com/anesthesia-analgesia/fulltext/2009/03000/methemoglobinemia_related_to_local_anesthetics__a.27.aspx
  90. https://iowaprotocols.medicine.uiowa.edu/protocols/maximum-recommended-doses-and-duration-local-anesthetics
  91. https://asra.com/news-publications/asra-updates/blog-landing/guidelines/2020/11/01/checklist-for-treatment-of-local-anesthetic-systemic-toxicity
  92. https://pmc.ncbi.nlm.nih.gov/articles/PMC6813483/
  93. https://www.drugs.com/pregnancy/lidocaine.html
  94. https://www.drugs.com/pregnancy/bupivacaine.html
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC7607532/
  96. https://www.aao.org/biographies-detail/carl-koller-md
  97. https://journals.sagepub.com/doi/pdf/10.1177/0310057X0303100301
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC4335732/
  99. https://www.researchgate.net/publication/51829565_The_surgeons_Halsted_and_Hall_cocaine_and_the_discovery_of_dental_anesthesia_by_nerve_blocking
  100. https://www.ncbi.nlm.nih.gov/books/NBK537299/
  101. https://academic.oup.com/bja/article/102/6/729/262135
  102. https://pubmed.ncbi.nlm.nih.gov/20216034/
  103. https://www.sciencedirect.com/science/article/abs/pii/S0040402020308358
  104. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/procaine
  105. https://www.woodlibrarymuseum.org/museum/novocain/
  106. https://www.woodlibrarymuseum.org/museum/lidocaine/
  107. https://pubmed.ncbi.nlm.nih.gov/11895133/
  108. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/bupivacaine
  109. https://pmc.ncbi.nlm.nih.gov/articles/PMC3417942/
  110. https://newdrugapprovals.org/2021/10/28/ropivacaine/
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC3442744/
  112. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/209511Orig1s000MedR.pdf
  113. https://pubmed.ncbi.nlm.nih.gov/20364022/
  114. https://pmc.ncbi.nlm.nih.gov/articles/PMC11854925/
  115. https://pmc.ncbi.nlm.nih.gov/articles/PMC3106379/
  116. https://www.science.org/doi/10.1126/science.150.3699.971
  117. https://pmc.ncbi.nlm.nih.gov/articles/PMC4589923/
  118. https://pubmed.ncbi.nlm.nih.gov/5320816/
  119. https://www.ncbi.nlm.nih.gov/books/NBK482123/
  120. https://pmc.ncbi.nlm.nih.gov/articles/PMC10107282/
  121. https://www.nccih.nih.gov/health/acupuncture-effectiveness-and-safety
  122. https://www.nccih.nih.gov/research/research-results/how-the-body-and-brain-achieve-carpal-tunnel-pain-relief-via-acupuncture
  123. https://pmc.ncbi.nlm.nih.gov/articles/PMC11404884/
  124. https://pmc.ncbi.nlm.nih.gov/articles/PMC6446021/
  125. https://pmc.ncbi.nlm.nih.gov/articles/PMC5932994/
  126. https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-avoid-certain-topical-pain-relief-products-due-potential-dangerous-health
  127. https://www.mayoclinic.org/drugs-supplements/lidocaine-topical-application-route/description/drg-20072776
  128. https://go.drugbank.com/drugs/DB01086
  129. https://www.empr.com/home/news/safety-alerts-and-recalls/companies-selling-topical-analgesic-products-get-fda-warning-letter/
  130. https://www.fda.gov/drugs/drug-safety-and-availability/risk-serious-and-potentially-fatal-blood-disorder-prompts-fda-action-oral-over-counter-benzocaine
  131. https://www.poison.org/articles/lidocaine-can-cause-harmful-effects-172
  132. https://www.fda.gov/drugs/otc-drug-review-process-otc-drug-monographs
  133. https://www.fda.gov/about-fda/fda-history-exhibits/drug-therapeutics-regulation-us
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.